نتایج جستجو برای: rifampicin resistance

تعداد نتایج: 378893  

2012
B. ANDERSEN

Anti-tuberculosis drug resistance is a major problem in tuberculosis (TB) control, particularly multi-drug resistance TB (MDR-TB). The objective of this study was to determine the prevalence of primary and acquired anti-TB drug resistance among newly diagnosed pulmonary TB (PTB) and relapse cases. Sputa were collected from newly diagnosed and relapse PTB patients. Drug susceptibility tests (DST...

Journal: :The Journal of antimicrobial chemotherapy 2010
Jurriaan E M de Steenwinkel Gerjo J de Knegt Marian T ten Kate Alex van Belkum Henri A Verbrugh Kristin Kremer Dick van Soolingen Irma A J M Bakker-Woudenberg

OBJECTIVES The pharmacodynamics of tuberculosis (TB) treatment should be further explored, to prevent emergence of resistance, treatment failure and relapse of infection. The diagnostic drug susceptibility tests guiding TB therapy investigate metabolically active Mycobacterium tuberculosis (Mtb) isolates under static conditions and as such are not informative with respect to the time-kill kinet...

2013
Francis Drobniewski Vladyslav Nikolayevskyy Horst Maxeiner Yanina Balabanova Nicola Casali Irina Kontsevaya Olga Ignatyeva

In this article, we give an overview of new technologies for the diagnosis of tuberculosis (TB) and drug resistance, consider their advantages over existing methodologies, broad issues of cost, cost-effectiveness and programmatic implementation, and their clinical as well as public health impact, focusing on the industrialized world. Molecular nucleic-acid amplification diagnostic systems have ...

2015
Yanmin Hu Alexander Liu Fatima Ortega-Muro Laura Alameda-Martin Denis Mitchison Anthony Coates

Although high-dose rifampicin holds promise for improving tuberculosis control by potentially shortening treatment duration, these effects attributed to eradication of persistent bacteria are unclear. The presence of persistent Mycobacterium tuberculosis was examined using resuscitation promoting factors (RPFs) in both in vitro hypoxia and in vivo murine tuberculosis models before and after tre...

2016
Marco Galarza Manuel Fasabi Kelly S. Levano Edith Castillo Nadia Barreda Mitzi Rodriguez Heinner Guio

BACKGROUND The emergence of multidrug-resistant strains is a major health problem especially for countries with high TB incidence such as Peru. In this study, we evaluated High Resolution Melting (HRM) assay in Peruvian isolates for the detection of mutations within rpoB, katG genes and promoter region inhA to determine isoniazid and rifampicin resistance in Mycobacterium tuberculosis (Mtb). ...

2013
Dorai Deepa Shanta Achanta Jyoti Jaju Koteswara Rao Rani Samyukta Mareli Claassens Ajay M. V. Kumar Vishnu PH

BACKGROUND Multi drug resistant and rifampicin resistant TB patients in India are treated with the World Health Organization (WHO) recommended standardized treatment regimens but no guidelines are available for the management of isoniazid (INH) resistant TB patients. There have been concerns that the standard eight-month retreatment regimen being used in India (2H3R3Z3E3S3/1H3R3Z3E3/5H3R3E3; H-...

2015
Paulo Durão Sandra Trindade Ana Sousa Isabel Gordo

Evidence is mounting that epistasis is widespread among mutations. The cost of carrying two deleterious mutations, or the advantage of acquiring two beneficial alleles, is typically lower that the sum of their individual effects. Much less is known on epistasis between beneficial and deleterious mutations, even though this is key to the amount of genetic hitchhiking that may occur during evolut...

Journal: :The Journal of antimicrobial chemotherapy 2008
Steven N Leonard Glenn W Kaatz Latoyia R Rucker Michael J Rybak

OBJECTIVES The rapid emergence of methicillin-resistant Staphylococcus aureus from the community (CA-MRSA) presents difficulties in making treatment choices. We evaluated whether combining another orally available agent commonly used to treat CA-MRSA with gemifloxacin would enhance gemifloxacin activity against CA-MRSA. METHODS Fifty strains of SCCmec IV, agr group 1, Panton-Valentine leucoci...

2015
Keira A. Cohen Thomas Abeel Abigail Manson McGuire Christopher A. Desjardins Vanisha Munsamy Terrance P. Shea Bruce J. Walker Nonkqubela Bantubani Deepak V. Almeida Lucia Alvarado Sinéad B. Chapman Nomonde R. Mvelase Eamon Y. Duffy Michael G. Fitzgerald Pamla Govender Sharvari Gujja Susanna Hamilton Clinton Howarth Jeffrey D. Larimer Kashmeel Maharaj Matthew D. Pearson Margaret E. Priest Qiandong Zeng Nesri Padayatchi Jacques Grosset Sarah K. Young Jennifer Wortman Koleka P. Mlisana Max R. O'Donnell Bruce W. Birren William R. Bishai Alexander S. Pym Ashlee M. Earl John Z Metcalfe

BACKGROUND The continued advance of antibiotic resistance threatens the treatment and control of many infectious diseases. This is exemplified by the largest global outbreak of extensively drug-resistant (XDR) tuberculosis (TB) identified in Tugela Ferry, KwaZulu-Natal, South Africa, in 2005 that continues today. It is unclear whether the emergence of XDR-TB in KwaZulu-Natal was due to recent i...

2013
Nguyen Thi Le Hang Shinji Maeda Luu Thi Lien Pham Huu Thuong Nguyen Van Hung Tran Bich Thuy Akiko Nanri Tetsuya Mizoue Nguyen Phuong Hoang Vu Cao Cuong Khieu Thi Thuy Ngoc Shinsaku Sakurada Hiroyoshi Endo Naoto Keicho

INTRODUCTION Resistance of Mycobacterium tuberculosis (MTB) to anti-tuberculosis (TB) drugs presents a serious challenge to TB control worldwide. We investigated the status of drug resistance, including multidrug-resistant (MDR) TB, and possible risk factors among newly diagnosed TB patients in Hanoi, the capital of Viet Nam. METHODS Clinical and epidemiological information was collected from...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید